PLIANT THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
PLIANT THERAPEUTICS, INC. (PLRX) had Common Stock, Capital Shares Reserved for Future Issuance of 21.87 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-11
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 21.87M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 21.87M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 19.26M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 19.26M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 21.87M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 21.87M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 19.26M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 19.26M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 19.33M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 19.33M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 16.20M shares 10-K · filed 2026-03-11 |
| 2024-09-30 | 15.21M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 15.64M shares 10-Q · filed 2024-08-07 |
| 2024-03-31 | 15.74M shares 10-Q · filed 2024-05-06 |
| 2023-12-31 | 12.54M shares 10-K · filed 2025-03-03 |
| 2023-09-30 | 12.58M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 14.24M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 13.31M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 11.44M shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 10.69M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 10.50M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 10.56M shares 10-Q · filed 2022-05-09 |
| 2021-12-31 | 8.47M shares 10-K · filed 2023-03-09 |
| 2021-09-30 | 8.59M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 8.75M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 8.91M shares 10-Q · filed 2021-05-10 |
| 2020-12-31 | 7.34M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 7.42M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 7.43M shares 10-Q · filed 2020-08-11 |
| 2019-12-31 | 20.35M shares 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |